{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T09:33:25Z","timestamp":1790501605524,"version":"4.1.0"},"reference-count":117,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T00:00:00Z","timestamp":1535500800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIH","award":["R21NS090205"],"award-info":[{"award-number":["R21NS090205"]}]},{"name":"NIH","award":["AG-017586"],"award-info":[{"award-number":["AG-017586"]}]},{"name":"NIH","award":["R01 NS095746-01"],"award-info":[{"award-number":["R01 NS095746-01"]}]},{"name":"NIH","award":["R21NS093439"],"award-info":[{"award-number":["R21NS093439"]}]},{"name":"NIH","award":["5R21NS087077-02"],"award-info":[{"award-number":["5R21NS087077-02"]}]},{"name":"NIH","award":["R01GM099836"],"award-info":[{"award-number":["R01GM099836"]}]},{"name":"NIH","award":["5R01NS073660"],"award-info":[{"award-number":["5R01NS073660"]}]},{"name":"NIH","award":["R35NS097275"],"award-info":[{"award-number":["R35NS097275"]}]},{"name":"NIH","award":["R01NS095793"],"award-info":[{"award-number":["R01NS095793"]}]},{"name":"NIH","award":["AG10124"],"award-info":[{"award-number":["AG10124"]}]},{"name":"NIH","award":["AG10124"],"award-info":[{"award-number":["AG10124"]}]},{"name":"NIH","award":["AG17586"],"award-info":[{"award-number":["AG17586"]}]},{"name":"NIH","award":["AG17586"],"award-info":[{"award-number":["AG17586"]}]},{"name":"Life Extension Foundation"},{"DOI":"10.13039\/100000971","name":"ALS Association","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000971","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Department of Biochemistry and Biophysics Pilot Grant"},{"DOI":"10.13039\/100013013","name":"Target ALS","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100013013","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Glenn Foundation"},{"name":"The Robert Packard Center for ALS Research at Johns Hopkins"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s40478-018-0586-1","type":"journal-article","created":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T12:23:09Z","timestamp":1535545389000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":114,"title":["Nuclear poly(ADP-ribose) activity is a therapeutic target in amyotrophic lateral sclerosis"],"prefix":"10.1186","volume":"6","author":[{"given":"L.","family":"McGurk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Mojsilovic-Petrovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. M.","family":"Van Deerlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Shorter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. G.","family":"Kalb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. M.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Q.","family":"Trojanowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. B.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. M.","family":"Bonini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,29]]},"reference":[{"key":"586_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cellsig.2011.07.019","volume":"24","author":"ZY Abd Elmageed","year":"2012","unstructured":"Abd Elmageed ZY, Naura AS, Errami Y, Zerfaoui M (2012) The poly(ADP-ribose) polymerases (PARPs): new roles in intracellular transport. Cell Signal 24:1\u20138. \n                    https:\/\/doi.org\/10.1016\/j.cellsig.2011.07.019","journal-title":"Cell Signal"},{"key":"586_CR2","first-page":"255","volume":"7","author":"GE Abdelkarim","year":"2001","unstructured":"Abdelkarim GE, Gertz K, Harms C, Katchanov J, Dirnagl U, Szabo C, Endres M (2001) Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke. Int J Mol Med 7:255\u2013260","journal-title":"Int J Mol Med"},{"key":"586_CR3","doi-asserted-by":"publisher","first-page":"8088","DOI":"10.1038\/ncomms9088","volume":"6","author":"M Altmeyer","year":"2015","unstructured":"Altmeyer M, Neelsen KJ, Teloni F, Pozdnyakova I, Pellegrino S, Grofte M, Rask MB, Streicher W, Jungmichel S, Nielsen ML et al (2015) Liquid demixing of intrinsically disordered proteins is seeded by poly(ADP-ribose). Nat Commun 6:8088. \n                    https:\/\/doi.org\/10.1038\/ncomms9088","journal-title":"Nat Commun"},{"key":"586_CR4","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.tibs.2007.12.003","volume":"33","author":"P Anderson","year":"2008","unstructured":"Anderson P, Kedersha N (2008) Stress granules: the Tao of RNA triage. Trends Biochem Sci 33:141\u2013150. \n                    https:\/\/doi.org\/10.1016\/j.tibs.2007.12.003","journal-title":"Trends Biochem Sci"},{"key":"586_CR5","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/nm.2387","volume":"17","author":"SA Andrabi","year":"2011","unstructured":"Andrabi SA, Kang HC, Haince JF, Lee YI, Zhang J, Chi Z, West AB, Koehler RC, Poirier GG, Dawson TM et al (2011) Iduna protects the brain from glutamate excitotoxicity and stroke by interfering with poly(ADP-ribose) polymer-induced cell death. Nat Med 17:692\u2013699. \n                    https:\/\/doi.org\/10.1038\/nm.2387","journal-title":"Nat Med"},{"key":"586_CR6","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1006\/exnr.2001.7633","volume":"168","author":"OA Andreassen","year":"2001","unstructured":"Andreassen OA, Dedeoglu A, Friedlich A, Ferrante KL, Hughes D, Szabo C, Beal MF (2001) Effects of an inhibitor of poly(ADP-ribose) polymerase, desmethylselegiline, trientine, and lipoic acid in transgenic ALS mice. Exp Neurol 168:419\u2013424. \n                    https:\/\/doi.org\/10.1006\/exnr.2001.7633","journal-title":"Exp Neurol"},{"key":"586_CR7","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3988\/jcn.2013.9.2.65","volume":"9","author":"JS Bae","year":"2013","unstructured":"Bae JS, Simon NG, Menon P, Vucic S, Kiernan MC (2013) The puzzling case of hyperexcitability in amyotrophic lateral sclerosis. J Clin Neurol 9:65\u201374. \n                    https:\/\/doi.org\/10.3988\/jcn.2013.9.2.65","journal-title":"J Clin Neurol"},{"key":"586_CR8","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nature22038","volume":"544","author":"LA Becker","year":"2017","unstructured":"Becker LA, Huang B, Bieri G, Ma R, Knowles DA, Jafar-Nejad P, Messing J, Kim HJ, Soriano A, Auburger G et al (2017) Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice. Nature 544:367\u2013371. \n                    https:\/\/doi.org\/10.1038\/nature22038","journal-title":"Nature"},{"key":"586_CR9","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s13167-010-0026-1","volume":"1","author":"C Benkler","year":"2010","unstructured":"Benkler C, Offen D, Melamed E, Kupershmidt L, Amit T, Mandel S, Youdim MB, Weinreb O (2010) Recent advances in amyotrophic lateral sclerosis research: perspectives for personalized clinical application. EPMA J 1:343\u2013361. \n                    https:\/\/doi.org\/10.1007\/s13167-010-0026-1","journal-title":"EPMA J"},{"key":"586_CR10","doi-asserted-by":"publisher","first-page":"23079","DOI":"10.1074\/jbc.M111.328757","volume":"287","author":"E Bentmann","year":"2012","unstructured":"Bentmann E, Neumann M, Tahirovic S, Rodde R, Dormann D, Haass C (2012) Requirements for stress granule recruitment of fused in sarcoma (FUS) and TAR DNA-binding protein of 43 kDa (TDP-43). J Biol Chem 287:23079\u201323094. \n                    https:\/\/doi.org\/10.1074\/jbc.M111.328757","journal-title":"J Biol Chem"},{"key":"586_CR11","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/bph.13748","volume":"175","author":"NA Berger","year":"2018","unstructured":"Berger NA, Besson VC, Boulares AH, Burkle A, Chiarugi A, Clark RS, Curtin NJ, Cuzzocrea S, Dawson TM, Dawson VL et al (2018) Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases. Br J Pharmacol 175:192\u2013222. \n                    https:\/\/doi.org\/10.1111\/bph.13748","journal-title":"Br J Pharmacol"},{"key":"586_CR12","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","volume":"112","author":"H Braak","year":"2006","unstructured":"Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112:389\u2013404. \n                    https:\/\/doi.org\/10.1007\/s00401-006-0127-z","journal-title":"Acta Neuropathol"},{"key":"586_CR13","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239\u2013259","journal-title":"Acta Neuropathol"},{"key":"586_CR14","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00401-014-1299-6","volume":"128","author":"J Brettschneider","year":"2014","unstructured":"Brettschneider J, Arai K, Del Tredici K, Toledo JB, Robinson JL, Lee EB, Kuwabara S, Shibuya K, Irwin DJ, Fang L et al (2014) TDP-43 pathology and neuronal loss in amyotrophic lateral sclerosis spinal cord. Acta Neuropathol 128:423\u2013437. \n                    https:\/\/doi.org\/10.1007\/s00401-014-1299-6","journal-title":"Acta Neuropathol"},{"key":"586_CR15","doi-asserted-by":"publisher","unstructured":"Brettschneider J, Del Tredici K, Toledo JB, Robinson JL, Irwin DJ, Grossman M, Suh E, Van Deerlin VM, Wood EM, Baek Y et al (2013) Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann Neurol 74: 20\u201338 Doi \n                    https:\/\/doi.org\/10.1002\/ana.23937","DOI":"10.1002\/ana.23937"},{"key":"586_CR16","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/nature03443","volume":"434","author":"HE Bryant","year":"2005","unstructured":"Bryant HE, Schultz N, Thomas HD, Parker KM, Flower D, Lopez E, Kyle S, Meuth M, Curtin NJ, Helleday T (2005) Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature 434:913\u2013917. \n                    https:\/\/doi.org\/10.1038\/nature03443","journal-title":"Nature"},{"key":"586_CR17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1093\/jnci\/djh005","volume":"96","author":"CR Calabrese","year":"2004","unstructured":"Calabrese CR, Almassy R, Barton S, Batey MA, Calvert AH, Canan-Koch S, Durkacz BW, Hostomsky Z, Kumpf RA, Kyle S et al (2004) Anticancer chemosensitization and radiosensitization by the novel poly(ADP-ribose) polymerase-1 inhibitor AG14361. J Natl Cancer Inst 96:56\u201367","journal-title":"J Natl Cancer Inst"},{"key":"586_CR18","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.dnarep.2014.03.021","volume":"19","author":"KW Caldecott","year":"2014","unstructured":"Caldecott KW (2014) Protein ADP-ribosylation and the cellular response to DNA strand breaks. DNA Repair (Amst) 19:108\u2013113. \n                    https:\/\/doi.org\/10.1016\/j.dnarep.2014.03.021","journal-title":"DNA Repair (Amst)"},{"key":"586_CR19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.phrs.2005.02.018","volume":"52","author":"A Chiarugi","year":"2005","unstructured":"Chiarugi A (2005) Poly(ADP-ribosyl)ation and stroke. Pharmacol Res 52:15\u201324. \n                    https:\/\/doi.org\/10.1016\/j.phrs.2005.02.018","journal-title":"Pharmacol Res"},{"key":"586_CR20","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1124\/jpet.103.048934","volume":"305","author":"A Chiarugi","year":"2003","unstructured":"Chiarugi A, Meli E, Calvani M, Picca R, Baronti R, Camaioni E, Costantino G, Marinozzi M, Pellegrini-Giampietro DE, Pellicciari R et al (2003) Novel isoquinolinone-derived inhibitors of poly(ADP-ribose) polymerase-1: pharmacological characterization and neuroprotective effects in an in vitro model of cerebral ischemia. J Pharmacol Exp Ther 305:943\u2013949. \n                    https:\/\/doi.org\/10.1124\/jpet.103.048934","journal-title":"J Pharmacol Exp Ther"},{"key":"586_CR21","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.imr.2014.09.005","volume":"3","author":"HT Chung","year":"2014","unstructured":"Chung HT, Joe Y (2014) Antagonistic crosstalk between SIRT1, PARP-1, and -2 in the regulation of chronic inflammation associated with aging and metabolic diseases. Integr Med Res 3:198\u2013203. \n                    https:\/\/doi.org\/10.1016\/j.imr.2014.09.005","journal-title":"Integr Med Res"},{"key":"586_CR22","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.brainres.2004.01.010","volume":"1003","author":"YH Chung","year":"2004","unstructured":"Chung YH, Joo KM, Lee YJ, Shin DH, Cha CI (2004) Reactive astrocytes express PARP in the central nervous system of SOD(G93A) transgenic mice. Brain Res 1003:199\u2013204. \n                    https:\/\/doi.org\/10.1016\/j.brainres.2004.01.010","journal-title":"Brain Res"},{"key":"586_CR23","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/1471-2148-10-308","volume":"10","author":"M Citarelli","year":"2010","unstructured":"Citarelli M, Teotia S, Lamb RS (2010) Evolutionary history of the poly(ADP-ribose) polymerase gene family in eukaryotes. BMC Evol Biol 10:308. \n                    https:\/\/doi.org\/10.1186\/1471-2148-10-308","journal-title":"BMC Evol Biol"},{"key":"586_CR24","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/jnr.490390106","volume":"39","author":"C Cosi","year":"1994","unstructured":"Cosi C, Suzuki H, Milani D, Facci L, Menegazzi M, Vantini G, Kanai Y, Skaper SD (1994) Poly(ADP-ribose) polymerase: early involvement in glutamate-induced neurotoxicity in cultured cerebellar granule cells. J Neurosci Res 39:38\u201346. \n                    https:\/\/doi.org\/10.1002\/jnr.490390106","journal-title":"J Neurosci Res"},{"key":"586_CR25","doi-asserted-by":"publisher","first-page":"10262","DOI":"10.1523\/JNEUROSCI.2818-05.2005","volume":"25","author":"C Culmsee","year":"2005","unstructured":"Culmsee C, Zhu C, Landshamer S, Becattini B, Wagner E, Pellecchia M, Blomgren K, Plesnila N (2005) Apoptosis-inducing factor triggered by poly(ADP-ribose) polymerase and bid mediates neuronal cell death after oxygen-glucose deprivation and focal cerebral ischemia. J Neurosci 25:10262\u201310272. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.2818-05.2005","journal-title":"J Neurosci"},{"key":"586_CR26","doi-asserted-by":"publisher","unstructured":"Dash RP, Babu RJ, Srinivas NR (2018) Two decades-long journey from Riluzole to Edaravone: revisiting the clinical pharmacokinetics of the only two amyotrophic lateral sclerosis therapeutics. Clin Pharmacokinet. \n                    https:\/\/doi.org\/10.1007\/s40262-018-0655-4","DOI":"10.1007\/s40262-018-0655-4"},{"key":"586_CR27","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1023\/B:JOBB.0000041755.22613.8d","volume":"36","author":"VL Dawson","year":"2004","unstructured":"Dawson VL, Dawson TM (2004) Deadly conversations: nuclear-mitochondrial cross-talk. J Bioenerg Biomembr 36:287\u2013294. \n                    https:\/\/doi.org\/10.1023\/B:JOBB.0000041755.22613.8d","journal-title":"J Bioenerg Biomembr"},{"key":"586_CR28","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","volume":"72","author":"M DeJesus-Hernandez","year":"2011","unstructured":"DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, Nicholson AM, Finch NA, Flynn H, Adamson J et al (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72:245\u2013256. \n                    https:\/\/doi.org\/10.1016\/j.neuron.2011.09.011","journal-title":"Neuron"},{"key":"586_CR29","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nature09320","volume":"466","author":"AC Elden","year":"2010","unstructured":"Elden AC, Kim HJ, Hart MP, Chen-Plotkin AS, Johnson BS, Fang X, Armakola M, Geser F, Greene R, Lu MM et al (2010) Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature 466:1069\u20131075. \n                    https:\/\/doi.org\/10.1038\/nature09320","journal-title":"Nature"},{"key":"586_CR30","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S0014-2999(98)00381-1","volume":"351","author":"M Endres","year":"1998","unstructured":"Endres M, Scott GS, Salzman AL, Kun E, Moskowitz MA, Szabo C (1998) Protective effects of 5-iodo-6-amino-1,2-benzopyrone, an inhibitor of poly(ADP-ribose) synthetase against peroxynitrite-induced glial damage and stroke development. Eur J Pharmacol 351:377\u2013382","journal-title":"Eur J Pharmacol"},{"key":"586_CR31","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1097\/00004647-199711000-00002","volume":"17","author":"M Endres","year":"1997","unstructured":"Endres M, Wang ZQ, Namura S, Waeber C, Moskowitz MA (1997) Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase. J Cereb Blood Flow Metab 17:1143\u20131151. \n                    https:\/\/doi.org\/10.1097\/00004647-199711000-00002","journal-title":"J Cereb Blood Flow Metab"},{"key":"586_CR32","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1093\/hmg\/ddx170","volume":"26","author":"MA Farg","year":"2017","unstructured":"Farg MA, Konopka A, Soo KY, Ito D, Atkin JD (2017) The DNA damage response (DDR) is induced by the C9orf72 repeat expansion in amyotrophic lateral sclerosis. Hum Mol Genet 26:2882\u20132896. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddx170","journal-title":"Hum Mol Genet"},{"key":"586_CR33","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nature03445","volume":"434","author":"H Farmer","year":"2005","unstructured":"Farmer H, McCabe N, Lord CJ, Tutt AN, Johnson DA, Richardson TB, Santarosa M, Dillon KJ, Hickson I, Knights C et al (2005) Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434:917\u2013921. \n                    https:\/\/doi.org\/10.1038\/nature03445","journal-title":"Nature"},{"key":"586_CR34","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1111\/bph.12416","volume":"171","author":"AA Fatokun","year":"2014","unstructured":"Fatokun AA, Dawson VL, Dawson TM (2014) Parthanatos: mitochondrial-linked mechanisms and therapeutic opportunities. Br J Pharmacol 171:2000\u20132016. \n                    https:\/\/doi.org\/10.1111\/bph.12416","journal-title":"Br J Pharmacol"},{"key":"586_CR35","doi-asserted-by":"publisher","first-page":"3529","DOI":"10.1093\/hmg\/ddv104","volume":"24","author":"MJ Finelli","year":"2015","unstructured":"Finelli MJ, Liu KX, Wu Y, Oliver PL, Davies KE (2015) Oxr1 improves pathogenic cellular features of ALS-associated FUS and TDP-43 mutations. Hum Mol Genet 24:3529\u20133544. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddv104","journal-title":"Hum Mol Genet"},{"key":"586_CR36","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1001\/archneurol.2008.558","volume":"66","author":"F Geser","year":"2009","unstructured":"Geser F, Martinez-Lage M, Robinson J, Uryu K, Neumann M, Brandmeir NJ, Xie SX, Kwong LK, Elman L, McCluskey L et al (2009) Clinical and pathological continuum of multisystem TDP-43 proteinopathies. Arch Neurol 66:180\u2013189. \n                    https:\/\/doi.org\/10.1001\/archneurol.2008.558","journal-title":"Arch Neurol"},{"key":"586_CR37","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nrm3376","volume":"13","author":"BA Gibson","year":"2012","unstructured":"Gibson BA, Kraus WL (2012) New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs. Nat Rev Mol Cell Biol 13:411\u2013424. \n                    https:\/\/doi.org\/10.1038\/nrm3376","journal-title":"Nat Rev Mol Cell Biol"},{"key":"586_CR38","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1055\/s-0032-1329193","volume":"32","author":"SB Gibson","year":"2012","unstructured":"Gibson SB, Bromberg MB (2012) Amyotrophic lateral sclerosis: drug therapy from the bench to the bedside. Semin Neurol 32:173\u2013178. \n                    https:\/\/doi.org\/10.1055\/s-0032-1329193","journal-title":"Semin Neurol"},{"key":"586_CR39","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/21678421.2017.1364269","volume":"18","author":"Group AS","year":"2017","unstructured":"Group AS (2017) Open-label 24-week extension study of edaravone (MCI-186) in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 18:55\u201363. \n                    https:\/\/doi.org\/10.1080\/21678421.2017.1364269","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"586_CR40","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S1474-4422(17)30115-1","volume":"16","author":"Group AS","year":"2017","unstructured":"Group AS (2017) Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 16:505\u2013512. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(17)30115-1","journal-title":"Lancet Neurol"},{"key":"586_CR41","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1101\/gad.291518.116","volume":"31","author":"R Gupte","year":"2017","unstructured":"Gupte R, Liu Z, Kraus WL (2017) PARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes. Genes Dev 31:101\u2013126. \n                    https:\/\/doi.org\/10.1101\/gad.291518.116","journal-title":"Genes Dev"},{"key":"586_CR42","doi-asserted-by":"publisher","first-page":"6472","DOI":"10.2174\/1381612820666140630101525","volume":"20","author":"T Haikarainen","year":"2014","unstructured":"Haikarainen T, Krauss S, Lehtio L (2014) Tankyrases: structure, function and therapeutic implications in cancer. Curr Pharm Des 20:6472\u20136488","journal-title":"Curr Pharm Des"},{"key":"586_CR43","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1073\/pnas.2237114100","volume":"101","author":"S Hanai","year":"2004","unstructured":"Hanai S, Kanai M, Ohashi S, Okamoto K, Yamada M, Takahashi H, Miwa M (2004) Loss of poly(ADP-ribose) glycohydrolase causes progressive neurodegeneration in Drosophila melanogaster. Proc Natl Acad Sci U S A 101:82\u201386. \n                    https:\/\/doi.org\/10.1073\/pnas.2237114100","journal-title":"Proc Natl Acad Sci U S A"},{"key":"586_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.85","volume":"3","author":"O Hardiman","year":"2017","unstructured":"Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, Shaw PJ, Simmons Z, van den Berg LH (2017) Amyotrophic lateral sclerosis. Nat Rev Dis Primers 3:17085. \n                    https:\/\/doi.org\/10.1038\/nrdp.2017.85","journal-title":"Nat Rev Dis Primers"},{"key":"586_CR45","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/ana.21425","volume":"64","author":"M Hasegawa","year":"2008","unstructured":"Hasegawa M, Arai T, Nonaka T, Kametani F, Yoshida M, Hashizume Y, Beach TG, Buratti E, Baralle F, Morita M et al (2008) Phosphorylated TDP-43 in frontotemporal lobar degeneration and Amyotroph Lateral Scler. Ann Neurol 64:60\u201370. \n                    https:\/\/doi.org\/10.1002\/ana.21425","journal-title":"Ann Neurol"},{"key":"586_CR46","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1001\/archneurol.2010.52","volume":"67","author":"C Hewitt","year":"2010","unstructured":"Hewitt C, Kirby J, Highley JR, Hartley JA, Hibberd R, Hollinger HC, Williams TL, Ince PG, McDermott CJ, Shaw PJ (2010) Novel FUS\/TLS mutations and pathology in familial and sporadic amyotrophic lateral sclerosis. Arch Neurol 67:455\u2013461. \n                    https:\/\/doi.org\/10.1001\/archneurol.2010.52","journal-title":"Arch Neurol"},{"key":"586_CR47","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/nrneurol.2016.111","volume":"12","author":"EV Hobson","year":"2016","unstructured":"Hobson EV, McDermott CJ (2016) Supportive and symptomatic management of amyotrophic lateral sclerosis. Nat Rev Neurol 12:526\u2013538. \n                    https:\/\/doi.org\/10.1038\/nrneurol.2016.111","journal-title":"Nat Rev Neurol"},{"key":"586_CR48","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1146\/annurev-biochem-060614-034506","volume":"84","author":"MO Hottiger","year":"2015","unstructured":"Hottiger MO (2015) Nuclear ADP-Ribosylation and its role in chromatin plasticity, cell differentiation, and Epigenetics. Annu Rev Biochem 84:227\u2013263. \n                    https:\/\/doi.org\/10.1146\/annurev-biochem-060614-034506","journal-title":"Annu Rev Biochem"},{"key":"586_CR49","doi-asserted-by":"publisher","first-page":"4555","DOI":"10.1242\/jcs.106963","volume":"125","author":"M Isabelle","year":"2012","unstructured":"Isabelle M, Gagne JP, Gallouzi IE, Poirier GG (2012) Quantitative proteomics and dynamic imaging reveal that G3BP-mediated stress granule assembly is poly(ADP-ribose)-dependent following exposure to MNNG-induced DNA alkylation. J Cell Sci 125:4555\u20134566. \n                    https:\/\/doi.org\/10.1242\/jcs.106963","journal-title":"J Cell Sci"},{"key":"586_CR50","first-page":"3976","volume":"53","author":"SH Kaufmann","year":"1993","unstructured":"Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG (1993) Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res 53:3976\u20133985","journal-title":"Cancer Res"},{"key":"586_CR51","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/1742-2094-8-152","volume":"8","author":"TM Kauppinen","year":"2011","unstructured":"Kauppinen TM, Suh SW, Higashi Y, Berman AE, Escartin C, Won SJ, Wang C, Cho SH, Gan L, Swanson RA (2011) Poly(ADP-ribose)polymerase-1 modulates microglial responses to amyloid beta. J Neuroinflammation 8:152. \n                    https:\/\/doi.org\/10.1186\/1742-2094-8-152","journal-title":"J Neuroinflammation"},{"key":"586_CR52","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.1021\/bi00311a032","volume":"23","author":"H Kawamitsu","year":"1984","unstructured":"Kawamitsu H, Hoshino H, Okada H, Miwa M, Momoi H, Sugimura T (1984) Monoclonal antibodies to poly(adenosine diphosphate ribose) recognize different structures. Biochemistry 23:3771\u20133777","journal-title":"Biochemistry"},{"key":"586_CR53","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1083\/jcb.147.7.1431","volume":"147","author":"NL Kedersha","year":"1999","unstructured":"Kedersha NL, Gupta M, Li W, Miller I, Anderson P (1999) RNA-binding proteins TIA-1 and TIAR link the phosphorylation of eIF-2 alpha to the assembly of mammalian stress granules. J Cell Biol 147:1431\u20131442","journal-title":"J Cell Biol"},{"key":"586_CR54","doi-asserted-by":"publisher","first-page":"4257","DOI":"10.1158\/1078-0432.CCR-15-0887","volume":"21","author":"G Kim","year":"2015","unstructured":"Kim G, Ison G, McKee AE, Zhang H, Tang S, Gwise T, Sridhara R, Lee E, Tzou A, Philip R et al (2015) FDA approval summary: Olaparib monotherapy in patients with deleterious germline BRCA-mutated advanced ovarian Cancer treated with three or more lines of chemotherapy. Clin Cancer res 21:4257\u20134261. \n                    https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-0887","journal-title":"Clin Cancer res"},{"key":"586_CR55","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/ng.2853","volume":"46","author":"HJ Kim","year":"2014","unstructured":"Kim HJ, Raphael AR, LaDow ES, McGurk L, Weber RA, Trojanowski JQ, Lee VM, Finkbeiner S, Gitler AD, Bonini NM (2014) Therapeutic modulation of eIF2alpha phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models. Nat Genet 46:152\u2013160. \n                    https:\/\/doi.org\/10.1038\/ng.2853","journal-title":"Nat Genet"},{"key":"586_CR56","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1212\/01.WNL.0000103291.04985.DC","volume":"62","author":"SH Kim","year":"2004","unstructured":"Kim SH, Engelhardt JI, Henkel JS, Siklos L, Soos J, Goodman C, Appel SH (2004) Widespread increased expression of the DNA repair enzyme PARP in brain in ALS. Neurology 62:319\u2013322","journal-title":"Neurology"},{"key":"586_CR57","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1093\/jnen\/62.1.88","volume":"62","author":"SH Kim","year":"2003","unstructured":"Kim SH, Henkel JS, Beers DR, Sengun IS, Simpson EP, Goodman JC, Engelhardt JI, Siklos L, Appel SH (2003) PARP expression is increased in astrocytes but decreased in motor neurons in the spinal cord of sporadic ALS patients. J Neuropathol Exp Neurol 62:88\u2013103","journal-title":"J Neuropathol Exp Neurol"},{"key":"586_CR58","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.stem.2014.03.004","volume":"14","author":"E Kiskinis","year":"2014","unstructured":"Kiskinis E, Sandoe J, Williams LA, Boulting GL, Moccia R, Wainger BJ, Han S, Peng T, Thams S, Mikkilineni S et al (2014) Pathways disrupted in human ALS motor neurons identified through genetic correction of mutant SOD1. Cell Stem Cell 14:781\u2013795. \n                    https:\/\/doi.org\/10.1016\/j.stem.2014.03.004","journal-title":"Cell Stem Cell"},{"key":"586_CR59","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1460-9568.2005.04191.x","volume":"22","author":"SH Koh","year":"2005","unstructured":"Koh SH, Lee YB, Kim KS, Kim HJ, Kim M, Lee YJ, Kim J, Lee KW, Kim SH (2005) Role of GSK-3beta activity in motor neuronal cell death induced by G93A or A4V mutant hSOD1 gene. Eur J Neurosci 22:301\u2013309. \n                    https:\/\/doi.org\/10.1111\/j.1460-9568.2005.04191.x","journal-title":"Eur J Neurosci"},{"key":"586_CR60","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.molcel.2010.06.017","volume":"39","author":"R Krishnakumar","year":"2010","unstructured":"Krishnakumar R, Kraus WL (2010) The PARP side of the nucleus: molecular actions, physiological outcomes, and clinical targets. Mol Cell 39:8\u201324. \n                    https:\/\/doi.org\/10.1016\/j.molcel.2010.06.017","journal-title":"Mol Cell"},{"key":"586_CR61","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1126\/science.1166066","volume":"323","author":"TJ Kwiatkowski Jr","year":"2009","unstructured":"Kwiatkowski TJ Jr, Bosco DA, Leclerc AL, Tamrazian E, Vanderburg CR, Russ C, Davis A, Gilchrist J, Kasarskis EJ, Munsat T et al (2009) Mutations in the FUS\/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323:1205\u20131208. \n                    https:\/\/doi.org\/10.1126\/science.1166066","journal-title":"Science"},{"key":"586_CR62","doi-asserted-by":"publisher","first-page":"3576","DOI":"10.1111\/febs.12320","volume":"280","author":"L Lehtio","year":"2013","unstructured":"Lehtio L, Chi NW, Krauss S (2013) Tankyrases as drug targets. FEBS J 280:3576\u20133593. \n                    https:\/\/doi.org\/10.1111\/febs.12320","journal-title":"FEBS J"},{"key":"586_CR63","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1083\/jcb.201402114","volume":"205","author":"AK Leung","year":"2014","unstructured":"Leung AK (2014) Poly(ADP-ribose): an organizer of cellular architecture. J Cell Biol 205:613\u2013619. \n                    https:\/\/doi.org\/10.1083\/jcb.201402114","journal-title":"J Cell Biol"},{"key":"586_CR64","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1083\/jcb.201302044","volume":"201","author":"YR Li","year":"2013","unstructured":"Li YR, King OD, Shorter J, Gitler AD (2013) Stress granules as crucibles of ALS pathogenesis. J Cell Biol 201:361\u2013372. \n                    https:\/\/doi.org\/10.1083\/jcb.201302044","journal-title":"J Cell Biol"},{"key":"586_CR65","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.neuron.2013.07.033","volume":"79","author":"SC Ling","year":"2013","unstructured":"Ling SC, Polymenidou M, Cleveland DW (2013) Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron 79:416\u2013438. \n                    https:\/\/doi.org\/10.1016\/j.neuron.2013.07.033","journal-title":"Neuron"},{"key":"586_CR66","doi-asserted-by":"publisher","first-page":"e13250","DOI":"10.1371\/journal.pone.0013250","volume":"5","author":"L Liu-Yesucevitz","year":"2010","unstructured":"Liu-Yesucevitz L, Bilgutay A, Zhang YJ, Vanderweyde T, Citro A, Mehta T, Zaarur N, McKee A, Bowser R, Sherman M et al (2010) Tar DNA binding protein-43 (TDP-43) associates with stress granules: analysis of cultured cells and pathological brain tissue. PLoS One 5:e13250. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0013250","journal-title":"PLoS One"},{"key":"586_CR67","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1101\/gad.183509.111","volume":"26","author":"X Luo","year":"2012","unstructured":"Luo X, Kraus WL (2012) On PAR with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1. Genes Dev 26:417\u2013432. \n                    https:\/\/doi.org\/10.1101\/gad.183509.111","journal-title":"Genes Dev"},{"key":"586_CR68","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1021\/acs.chemrev.7b00122","volume":"118","author":"B Luscher","year":"2018","unstructured":"Luscher B, Butepage M, Eckei L, Krieg S, Verheugd P, Shilton BH (2018) ADP-Ribosylation, a multifaceted posttranslational modification involved in the control of cell physiology in health and disease. Chem Rev 118:1092\u20131136. \n                    https:\/\/doi.org\/10.1021\/acs.chemrev.7b00122","journal-title":"Chem Rev"},{"key":"586_CR69","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/ana.21147","volume":"61","author":"IR Mackenzie","year":"2007","unstructured":"Mackenzie IR, Bigio EH, Ince PG, Geser F, Neumann M, Cairns NJ, Kwong LK, Forman MS, Ravits J, Stewart H et al (2007) Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann Neurol 61:427\u2013434. \n                    https:\/\/doi.org\/10.1002\/ana.21147","journal-title":"Ann Neurol"},{"key":"586_CR70","doi-asserted-by":"publisher","first-page":"4611","DOI":"10.1111\/bph.14038","volume":"174","author":"L Mariotti","year":"2017","unstructured":"Mariotti L, Pollock K, Guettler S (2017) Regulation of Wnt\/beta-catenin signalling by tankyrase-dependent poly(ADP-ribosyl)ation and scaffolding. Br J Pharmacol 174:4611\u20134636. \n                    https:\/\/doi.org\/10.1111\/bph.14038","journal-title":"Br J Pharmacol"},{"key":"586_CR71","doi-asserted-by":"publisher","first-page":"e72169","DOI":"10.1371\/journal.pone.0072169","volume":"8","author":"S Martire","year":"2013","unstructured":"Martire S, Fuso A, Rotili D, Tempera I, Giordano C, De Zottis I, Muzi A, Vernole P, Graziani G, Lococo E et al (2013) PARP-1 modulates amyloid beta peptide-induced neuronal damage. PLoS One 8:e72169. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0072169","journal-title":"PLoS One"},{"key":"586_CR72","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.mad.2015.04.001","volume":"146-148","author":"S Martire","year":"2015","unstructured":"Martire S, Mosca L, d'Erme M (2015) PARP-1 involvement in neurodegeneration: a focus on Alzheimer's and Parkinson's diseases. Mech Ageing Dev 146-148:53\u201364. \n                    https:\/\/doi.org\/10.1016\/j.mad.2015.04.001\n                    \n                  .","journal-title":"Mech Ageing Dev"},{"key":"586_CR73","doi-asserted-by":"publisher","unstructured":"McGurk L, Gomes E, Guo L, Mojsilovic-Petrovic J, Tran V, Kalb RG, Shorter J, Bonini NM (2018) Poly(ADP-ribose) prevents pathological phase separation of TDP-43 by promoting liquid Demixing and stress granule localization. Mol Cell. \n                    https:\/\/doi.org\/10.1016\/j.molcel.2018.07.002\n                    \n                  .","DOI":"10.1016\/j.molcel.2018.07.002"},{"key":"586_CR74","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1097\/NEN.0000000000000102","volume":"73","author":"L McGurk","year":"2014","unstructured":"McGurk L, Lee VM, Trojanowksi JQ, Van Deerlin VM, Lee EB, Bonini NM (2014) Poly-A binding protein-1 localization to a subset of TDP-43 inclusions in amyotrophic lateral sclerosis occurs more frequently in patients harboring an expansion in C9orf72. J Neuropathol Exp Neurol 73:837\u2013845. \n                    https:\/\/doi.org\/10.1097\/NEN.0000000000000102\n                    \n                  .","journal-title":"J Neuropathol Exp Neurol"},{"key":"586_CR75","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG et al (2017) Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology 89:88\u2013100. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000004058","journal-title":"Neurology"},{"key":"586_CR76","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1212\/WNL.41.4.479","volume":"41","author":"SS Mirra","year":"1991","unstructured":"Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L (1991) The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41:479\u2013486","journal-title":"Neurology"},{"key":"586_CR77","doi-asserted-by":"publisher","first-page":"9250","DOI":"10.1523\/JNEUROSCI.1856-06.2006","volume":"26","author":"J Mojsilovic-Petrovic","year":"2006","unstructured":"Mojsilovic-Petrovic J, Jeong GB, Crocker A, Arneja A, David S, Russell DS, Kalb RG (2006) Protecting motor neurons from toxic insult by antagonism of adenosine A2a and Trk receptors. J Neurosci 26:9250\u20139263. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.1856-06.2006","journal-title":"J Neurosci"},{"key":"586_CR78","doi-asserted-by":"publisher","first-page":"8236","DOI":"10.1523\/JNEUROSCI.1805-09.2009","volume":"29","author":"J Mojsilovic-Petrovic","year":"2009","unstructured":"Mojsilovic-Petrovic J, Nedelsky N, Boccitto M, Mano I, Georgiades SN, Zhou W, Liu Y, Neve RL, Taylor JP, Driscoll M et al (2009) FOXO3a is broadly neuroprotective in vitro and in vivo against insults implicated in motor neuron diseases. J Neurosci 29:8236\u20138247. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.1805-09.2009","journal-title":"J Neurosci"},{"key":"586_CR79","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/sj.cdd.4400884","volume":"8","author":"F Moroni","year":"2001","unstructured":"Moroni F, Meli E, Peruginelli F, Chiarugi A, Cozzi A, Picca R, Romagnoli P, Pellicciari R, Pellegrini-Giampietro DE (2001) Poly(ADP-ribose) polymerase inhibitors attenuate necrotic but not apoptotic neuronal death in experimental models of cerebral ischemia. Cell Death Differ 8:921\u2013932. \n                    https:\/\/doi.org\/10.1038\/sj.cdd.4400884","journal-title":"Cell Death Differ"},{"key":"586_CR80","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1212\/WNL.39.9.1159","volume":"39","author":"JC Morris","year":"1989","unstructured":"Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, Mellits ED, Clark C (1989) The consortium to establish a registry for Alzheimer's disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 39:1159\u20131165","journal-title":"Neurology"},{"key":"586_CR81","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s41467-017-02299-1","volume":"9","author":"M Naumann","year":"2018","unstructured":"Naumann M, Pal A, Goswami A, Lojewski X, Japtok J, Vehlow A, Naujock M, Gunther R, Jin M, Stanslowsky N et al (2018) Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formation. Nat Commun 9:335. \n                    https:\/\/doi.org\/10.1038\/s41467-017-02299-1","journal-title":"Nat Commun"},{"key":"586_CR82","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s13167-010-0027-0","volume":"1","author":"B Nefussy","year":"2010","unstructured":"Nefussy B, Drory VE (2010) Moving toward a predictive and personalized clinical approach in amyotrophic lateral sclerosis: novel developments and future directions in diagnosis, genetics, pathogenesis and therapies. EPMA J 1:329\u2013341. \n                    https:\/\/doi.org\/10.1007\/s13167-010-0027-0","journal-title":"EPMA J"},{"key":"586_CR83","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00401-008-0477-9","volume":"117","author":"M Neumann","year":"2009","unstructured":"Neumann M, Kwong LK, Lee EB, Kremmer E, Flatley A, Xu Y, Forman MS, Troost D, Kretzschmar HA, Trojanowski JQ et al (2009) Phosphorylation of S409\/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies. Acta Neuropathol 117:137\u2013149. \n                    https:\/\/doi.org\/10.1007\/s00401-008-0477-9","journal-title":"Acta Neuropathol"},{"key":"586_CR84","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/01.jnen.0000248554.45456.58","volume":"66","author":"M Neumann","year":"2007","unstructured":"Neumann M, Kwong LK, Truax AC, Vanmassenhove B, Kretzschmar HA, Van Deerlin VM, Clark CM, Grossman M, Miller BL, Trojanowski JQ et al (2007) TDP-43-positive white matter pathology in frontotemporal lobar degeneration with ubiquitin-positive inclusions. J Neuropathol Exp Neurol 66:177\u2013183. \n                    https:\/\/doi.org\/10.1097\/01.jnen.0000248554.45456.58","journal-title":"J Neuropathol Exp Neurol"},{"key":"586_CR85","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM et al (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314:130\u2013133. \n                    https:\/\/doi.org\/10.1126\/science.1134108","journal-title":"Science"},{"key":"586_CR86","doi-asserted-by":"publisher","first-page":"e1002338","DOI":"10.1371\/journal.pgen.1002338","volume":"7","author":"PL Oliver","year":"2011","unstructured":"Oliver PL, Finelli MJ, Edwards B, Bitoun E, Butts DL, Becker EB, Cheeseman MT, Davies B, Davies KE (2011) Oxr1 is essential for protection against oxidative stress-induced neurodegeneration. PLoS Genet 7:e1002338. \n                    https:\/\/doi.org\/10.1371\/journal.pgen.1002338","journal-title":"PLoS Genet"},{"key":"586_CR87","doi-asserted-by":"publisher","first-page":"2896","DOI":"10.1161\/01.STR.0000147042.53659.6c","volume":"35","author":"EM Park","year":"2004","unstructured":"Park EM, Cho S, Frys K, Racchumi G, Zhou P, Anrather J, Iadecola C (2004) Interaction between inducible nitric oxide synthase and poly(ADP-ribose) polymerase in focal ischemic brain injury. Stroke 35:2896\u20132901. \n                    https:\/\/doi.org\/10.1161\/01.STR.0000147042.53659.6c","journal-title":"Stroke"},{"key":"586_CR88","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3389\/fnagi.2017.00068","volume":"9","author":"D Petrov","year":"2017","unstructured":"Petrov D, Mansfield C, Moussy A, Hermine O (2017) ALS clinical trials review: 20 years of failure. Are we any closer to registering a new treatment? Front Aging Neurosci 9:68. \n                    https:\/\/doi.org\/10.3389\/fnagi.2017.00068","journal-title":"Front Aging Neurosci"},{"key":"586_CR89","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neuron.2011.09.010","volume":"72","author":"AE Renton","year":"2011","unstructured":"Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, Schymick JC, Laaksovirta H, van Swieten JC, Myllykangas L et al (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72:257\u2013268. \n                    https:\/\/doi.org\/10.1016\/j.neuron.2011.09.010","journal-title":"Neuron"},{"key":"586_CR90","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/362059a0","volume":"362","author":"DR Rosen","year":"1993","unstructured":"Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng HX et al (1993) Mutations in cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59\u201362. \n                    https:\/\/doi.org\/10.1038\/362059a0","journal-title":"Nature"},{"key":"586_CR91","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s13311-014-0332-8","volume":"12","author":"J Rosenfeld","year":"2015","unstructured":"Rosenfeld J, Strong MJ (2015) Challenges in the understanding and treatment of amyotrophic lateral sclerosis\/motor neuron disease. Neurotherapeutics 12:317\u2013325. \n                    https:\/\/doi.org\/10.1007\/s13311-014-0332-8","journal-title":"Neurotherapeutics"},{"key":"586_CR92","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.cell.2017.10.011","volume":"171","author":"JD Rothstein","year":"2017","unstructured":"Rothstein JD (2017) Edaravone: a new drug approved for ALS. Cell 171:725. \n                    https:\/\/doi.org\/10.1016\/j.cell.2017.10.011","journal-title":"Cell"},{"key":"586_CR93","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/ana.410300223","volume":"30","author":"JD Rothstein","year":"1991","unstructured":"Rothstein JD, Kuncl R, Chaudhry V, Clawson L, Cornblath DR, Coyle JT, Drachman DB (1991) Excitatory amino acids in amyotrophic lateral sclerosis: an update. Ann Neurol 30:224\u2013225. \n                    https:\/\/doi.org\/10.1002\/ana.410300223","journal-title":"Ann Neurol"},{"key":"586_CR94","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/ana.410280106","volume":"28","author":"JD Rothstein","year":"1990","unstructured":"Rothstein JD, Tsai G, Kuncl RW, Clawson L, Cornblath DR, Drachman DB, Pestronk A, Stauch BL, Coyle JT (1990) Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann Neurol 28:18\u201325. \n                    https:\/\/doi.org\/10.1002\/ana.410280106","journal-title":"Ann Neurol"},{"key":"586_CR95","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1056\/NEJM200105313442207","volume":"344","author":"LP Rowland","year":"2001","unstructured":"Rowland LP, Shneider NA (2001) Amyotrophic lateral sclerosis. N Engl J Med 344:1688\u20131700. \n                    https:\/\/doi.org\/10.1056\/NEJM200105313442207","journal-title":"N Engl J Med"},{"key":"586_CR96","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/nar\/gkt835","volume":"42","author":"SL Rulten","year":"2014","unstructured":"Rulten SL, Rotheray A, Green RL, Grundy GJ, Moore DA, Gomez-Herreros F, Hafezparast M, Caldecott KW (2014) PARP-1 dependent recruitment of the amyotrophic lateral sclerosis-associated protein FUS\/TLS to sites of oxidative DNA damage. Nucleic Acids Res 42:307\u2013314. \n                    https:\/\/doi.org\/10.1093\/nar\/gkt835","journal-title":"Nucleic Acids Res"},{"key":"586_CR97","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1080\/14656566.2017.1319937","volume":"18","author":"H Sawada","year":"2017","unstructured":"Sawada H (2017) Clinical efficacy of edaravone for the treatment of amyotrophic lateral sclerosis. Expert Opin Pharmacother 18:735\u2013738. \n                    https:\/\/doi.org\/10.1080\/14656566.2017.1319937","journal-title":"Expert Opin Pharmacother"},{"key":"586_CR98","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/nn.2297","volume":"12","author":"S Saxena","year":"2009","unstructured":"Saxena S, Cabuy E, Caroni P (2009) A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice. Nat Neurosci 12:627\u2013636. \n                    https:\/\/doi.org\/10.1038\/nn.2297","journal-title":"Nat Neurosci"},{"key":"586_CR99","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nrm1963","volume":"7","author":"V Schreiber","year":"2006","unstructured":"Schreiber V, Dantzer F, Ame JC, de Murcia G (2006) Poly(ADP-ribose): novel functions for an old molecule. Nat Rev Mol Cell Biol 7:517\u2013528. \n                    https:\/\/doi.org\/10.1038\/nrm1963","journal-title":"Nat Rev Mol Cell Biol"},{"key":"586_CR100","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1006\/bbrc.1996.1889","volume":"229","author":"GM Shah","year":"1996","unstructured":"Shah GM, Shah RG, Poirier GG (1996) Different cleavage pattern for poly(ADP-ribose) polymerase during necrosis and apoptosis in HL-60 cells. Biochem Biophys Res Commun 229:838\u2013844. \n                    https:\/\/doi.org\/10.1006\/bbrc.1996.1889","journal-title":"Biochem Biophys Res Commun"},{"key":"586_CR101","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1006\/neur.1995.0026","volume":"4","author":"PJ Shaw","year":"1995","unstructured":"Shaw PJ, Forrest V, Ince PG, Richardson JP, Wastell HJ (1995) CSF and plasma amino acid levels in motor neuron disease: elevation of CSF glutamate in a subset of patients. Neurodegeneration 4:209\u2013216","journal-title":"Neurodegeneration"},{"key":"586_CR102","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/nrclinonc.2014.163","volume":"12","author":"A Sonnenblick","year":"2015","unstructured":"Sonnenblick A, de Azambuja E, Azim HA Jr, Piccart M (2015) An update on PARP inhibitors--moving to the adjuvant setting. Nat Rev Clin Oncol 12:27\u201341. \n                    https:\/\/doi.org\/10.1038\/nrclinonc.2014.163","journal-title":"Nat Rev Clin Oncol"},{"key":"586_CR103","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0022-510X(01)00661-X","volume":"193","author":"O Spreux-Varoquaux","year":"2002","unstructured":"Spreux-Varoquaux O, Bensimon G, Lacomblez L, Salachas F, Pradat PF, Le Forestier N, Marouan A, Dib M, Meininger V (2002) Glutamate levels in cerebrospinal fluid in amyotrophic lateral sclerosis: a reappraisal using a new HPLC method with coulometric detection in a large cohort of patients. J Neurol Sci 193:73\u201378","journal-title":"J Neurol Sci"},{"key":"586_CR104","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1126\/science.1154584","volume":"319","author":"J Sreedharan","year":"2008","unstructured":"Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B, Ackerley S, Durnall JC, Williams KL, Buratti E et al (2008) TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319:1668\u20131672. \n                    https:\/\/doi.org\/10.1126\/science.1154584","journal-title":"Science"},{"key":"586_CR105","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1097\/00004647-199711000-00001","volume":"17","author":"K Takahashi","year":"1997","unstructured":"Takahashi K, Greenberg JH, Jackson P, Maclin K, Zhang J (1997) Neuroprotective effects of inhibiting poly(ADP-ribose) synthetase on focal cerebral ischemia in rats. J Cereb Blood Flow Metab 17:1137\u20131142. \n                    https:\/\/doi.org\/10.1097\/00004647-199711000-00001","journal-title":"J Cereb Blood Flow Metab"},{"key":"586_CR106","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s40478-017-0480-2","volume":"5","author":"RH Tan","year":"2017","unstructured":"Tan RH, Yang Y, Kim WS, Dobson-Stone C, Kwok JB, Kiernan MC, Halliday GM (2017) Distinct TDP-43 inclusion morphologies in frontotemporal lobar degeneration with and without amyotrophic lateral sclerosis. Acta Neuropathol Commun 5:76. \n                    https:\/\/doi.org\/10.1186\/s40478-017-0480-2","journal-title":"Acta Neuropathol Commun"},{"key":"586_CR107","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature20413","volume":"539","author":"JP Taylor","year":"2016","unstructured":"Taylor JP, Brown RH Jr, Cleveland DW (2016) Decoding ALS: from genes to mechanism. Nature 539:197\u2013206. \n                    https:\/\/doi.org\/10.1038\/nature20413","journal-title":"Nature"},{"key":"586_CR108","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","volume":"58","author":"DR Thal","year":"2002","unstructured":"Thal DR, Rub U, Orantes M, Braak H (2002) Phases of a beta-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791\u20131800","journal-title":"Neurology"},{"key":"586_CR109","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3109\/10715762.2013.857018","volume":"48","author":"E Turunc Bayrakdar","year":"2014","unstructured":"Turunc Bayrakdar E, Uyanikgil Y, Kanit L, Koylu E, Yalcin A (2014) Nicotinamide treatment reduces the levels of oxidative stress, apoptosis, and PARP-1 activity in Abeta(1-42)-induced rat model of Alzheimer's disease. Free Radic Res 48:146\u2013158. \n                    https:\/\/doi.org\/10.3109\/10715762.2013.857018","journal-title":"Free Radic Res"},{"key":"586_CR110","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1097\/NEN.0b013e31817713b5","volume":"67","author":"K Uryu","year":"2008","unstructured":"Uryu K, Nakashima-Yasuda H, Forman MS, Kwong LK, Clark CM, Grossman M, Miller BL, Kretzschmar HA, Lee VM, Trojanowski JQ et al (2008) Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies. J Neuropathol Exp Neurol 67:555\u2013564. \n                    https:\/\/doi.org\/10.1097\/NEN.0b013e31817713b5","journal-title":"J Neuropathol Exp Neurol"},{"key":"586_CR111","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.bbadis.2006.05.002","volume":"1762","author":"L Van Den Bosch","year":"2006","unstructured":"Van Den Bosch L, Van Damme P, Bogaert E, Robberecht W (2006) The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis. Biochim Biophys Acta 1762:1068\u20131082. \n                    https:\/\/doi.org\/10.1016\/j.bbadis.2006.05.002","journal-title":"Biochim Biophys Acta"},{"key":"586_CR112","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1126\/science.1165942","volume":"323","author":"C Vance","year":"2009","unstructured":"Vance C, Rogelj B, Hortobagyi T, De Vos KJ, Nishimura AL, Sreedharan J, Hu X, Smith B, Ruddy D, Wright P et al (2009) Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323:1208\u20131211. \n                    https:\/\/doi.org\/10.1126\/science.1165942","journal-title":"Science"},{"key":"586_CR113","doi-asserted-by":"publisher","unstructured":"Wang Y, An R, Umanah GK, Park H, Nambiar K, Eacker SM, Kim B, Bao L, Harraz MM, Chang C et al (2016) A nuclease that mediates cell death induced by DNA damage and poly(ADP-ribose) polymerase-1. Science 354. \n                    https:\/\/doi.org\/10.1126\/science.aad6872","DOI":"10.1126\/science.aad6872"},{"key":"586_CR114","doi-asserted-by":"publisher","first-page":"ra20","DOI":"10.1126\/scisignal.2000902","volume":"4","author":"Y Wang","year":"2011","unstructured":"Wang Y, Kim NS, Haince JF, Kang HC, David KK, Andrabi SA, Poirier GG, Dawson VL, Dawson TM (2011) Poly(ADP-ribose) (PAR) binding to apoptosis-inducing factor is critical for PAR polymerase-1-dependent cell death (parthanatos). Sci Signal 4:ra20. \n                    https:\/\/doi.org\/10.1126\/scisignal.2000902","journal-title":"Sci Signal"},{"key":"586_CR115","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1002\/jnr.22310","volume":"88","author":"H Yokoyama","year":"2010","unstructured":"Yokoyama H, Kuroiwa H, Tsukada T, Uchida H, Kato H, Araki T (2010) Poly(ADP-ribose)polymerase inhibitor can attenuate the neuronal death after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice. J Neurosci Res 88:1522\u20131536. \n                    https:\/\/doi.org\/10.1002\/jnr.22310","journal-title":"J Neurosci Res"},{"key":"586_CR116","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1126\/science.8080500","volume":"263","author":"J Zhang","year":"1994","unstructured":"Zhang J, Dawson VL, Dawson TM, Snyder SH (1994) Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science 263:687\u2013689","journal-title":"Science"},{"key":"586_CR117","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.cell.2018.03.025","volume":"173","author":"K Zhang","year":"2018","unstructured":"Zhang K, Daigle JG, Cunningham KM, Coyne AN, Ruan K, Grima JC, Bowen KE, Wadhwa H, Yang P, Rigo F et al (2018) Stress Granule Assembly Disrupts Nucleocytoplasmic Transport. Cell 173:958\u2013971 e917. \n                    https:\/\/doi.org\/10.1016\/j.cell.2018.03.025","journal-title":"Cell"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-018-0586-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40478-018-0586-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-018-0586-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T19:14:51Z","timestamp":1567019691000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-018-0586-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,29]]},"references-count":117,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["586"],"URL":"https:\/\/doi.org\/10.1186\/s40478-018-0586-1","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,29]]},"assertion":[{"value":"16 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Informed consent was obtained from next of kin in accordance with institutional review board guidelines of the University of Pennsylvania.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consent to publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"84"}}